SQZ Biotechnologies Co
SQZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.83M
Close$
Share Statistics
| Market cap | $12.83 Million |
|---|---|
| Enterprise Value | $24.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.72 |
| Beta | 2.71 |
| Outstanding Shares | 29,491,125 |
Return
| Return on Equity | -180.60% |
|---|---|
| Return on Assets | -11.40% |
| Return on Invested Capital | -349.27% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | -0.33 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | 11.42 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SQZ Biotechnologies Co
98 employeesSQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies off...